The Global Pharmaceutical Grade Lopromide Market was valued at USD 386.2 Million in 2025 and is projected to reach USD 665.8 Million by 2034, growing at a Compound Annual Growth Rate (CAGR) of 5.8% during the forecast period (2024–2030). This growth is being driven by the rising global prevalence of chronic diseases requiring diagnostic imaging, an aging population, and technological advancements in medical imaging technologies.

As the medical diagnostics industry evolves toward more precise and safer imaging solutions, the spotlight is on the key active pharmaceutical ingredient (API) suppliers who are ensuring the quality, safety, and supply of contrast media. In this blog, we profile the Top 10 Companies in the Pharmaceutical Grade Lopromide Industry—a mix of global pharmaceutical giants, specialized chemical producers, and regional leaders shaping the future of diagnostic imaging.

---

🔟 1. Bayer AG

Headquarters: Leverkusen, Germany
Key Offering: High-Purity Lopromide API (Purity ≥99%)

Bayer AG is a global leader in the contrast media market and a pivotal supplier of Pharmaceutical Grade Lopromide. The company leverages its deep expertise in imaging diagnostics, with lopromide serving as a critical component for its branded contrast agents used in CT scans worldwide. Bayer’s commitment to stringent quality control and extensive clinical research underpins its leadership position.

Innovation and Quality Initiatives:

• Continuous process optimization for ultra-high purity API production

• Investment in R&D for next-generation, low-osmolar contrast media

• Global supply chain resilience and quality assurance programs adhering to cGMP

Download FREE Sample Report: Pharmaceutical Grade Lopromide Market – View in Detailed Research Report

---

9️⃣ 2. Alp Pharm Beijing Co., Ltd.

Headquarters: Beijing, China
Key Offering: Pharmaceutical Grade Lopromide (Purity ≥97%, ≥99%)

Alp Pharm Beijing is a leading Chinese manufacturer specializing in high-quality pharmaceutical intermediates and APIs, including lopromide. The company has established a strong reputation for its technical capabilities and cost-effective production, serving both domestic and international markets. Its focus on scaling production to meet growing global demand is a key strength.

Innovation and Quality Initiatives:

• Expansion of manufacturing capacity to capitalize on market growth

• Strategic focus on meeting international regulatory standards (USP, EP)

---

8️⃣ 3. Sichuan Ren’an Pharmaceutical

Headquarters: Sichuan, China
Key Offering: Lopromide API for Injectable Formulations

Sichuan Ren’an Pharmaceutical is a key player in the Chinese pharmaceutical chemical industry, with significant production capabilities for lopromide. The company plays a crucial role in the supply chain for contrast media manufacturers, particularly within the Asia-Pacific region, and is expanding its global footprint.

Innovation and Quality Initiatives:

• Vertical integration in the production of iodine-based contrast media APIs

• Investment in green chemistry and efficient synthesis routes

---

7️⃣ 4. Haihang Industry Co., Ltd.

Headquarters: Jinan, China
Key Offering: Lopromide (Pharmaceutical Grade)

Haihang Industry is a diversified chemical supplier with a portfolio that includes Pharmaceutical Grade Lopromide. The company serves a global clientele, offering competitive pricing and reliable supply, making it a significant vendor for formulation companies seeking high-quality raw materials.

Innovation and Quality Initiatives:

• Robust quality management systems

• Focus on building long-term partnerships with international distributors

---

6️⃣ 5. Taizhou Crene Biochem & Technology Co., Ltd.

Headquarters: Taizhou, China
Key Offering: Lopromide and other specialty pharmaceutical chemicals

Taizhou Crene specializes in the research, development, and production of fine chemicals and pharmaceutical intermediates. The company’s expertise in complex organic synthesis positions it as a reliable supplier of Pharmaceutical Grade Lopromide to the global market.

Innovation and Quality Initiatives:

• Custom synthesis and contract manufacturing services

• Commitment to environmental, health, and safety standards

Download FREE Sample Report: Pharmaceutical Grade Lopromide Market – View in Detailed Research Report

---

5️⃣ 6. Hubei Jiufengshan Pharmaceutical Co., Ltd.

Headquarters: Hubei, China
Key Offering: High-Purity Lopromide API

Hubei Jiufengshan Pharmaceutical is engaged in the manufacturing of APIs and pharmaceutical intermediates. The company contributes to the lopromide supply chain with a focus on serving the growing diagnostics market in China and abroad.

Innovation and Quality Initiatives:

• Modern production facilities adhering to GMP guidelines

• Focus on cost-competitive manufacturing without compromising on quality

---

4️⃣ 7. Zhejiang Kangle Pharmaceutical Co., Ltd.

Headquarters: Taizhou, China
Key Offering: Lopromide for Contrast Media Applications

Zhejiang Kangle Pharmaceutical is a manufacturer of APIs and intermediates, with lopromide being part of its specialty chemicals portfolio. The company leverages its chemical synthesis expertise to maintain a stable supply for the medical imaging industry.

Innovation and Quality Initiatives:

• Technological upgrades in purification processes

• Active participation in the pharmaceutical chemicals export market

---

3️⃣ 8. Shanghai UC Pharma Tech Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Pharmaceutical Intermediates including Lopromide

Shanghai UC Pharma Tech is a science-driven company specializing in the development and production of advanced pharmaceutical intermediates. Its capabilities in producing high-purity lopromide support the stringent requirements of contrast media manufacturers.

Innovation and Quality Initiatives:

• Strong R&D focus on innovative synthetic pathways

• Collaborations with academic and research institutions

---

2️⃣ 9. Chengdu Yuanda Pharmaceutical Co., Ltd.

Headquarters: Chengdu, China
Key Offering: Lopromide and other API chemicals

Chengdu Yuanda is a pharmaceutical company involved in the production of various APIs. Its role in the lopromide market is characterized by its contribution to the regional supply chain and its efforts to meet the quality standards demanded by the industry.

Innovation and Quality Initiatives:

• Implementation of strict quality control protocols

• Focus on sustainable manufacturing practices

---

1️⃣ 10. Jiangsu Nhool Pharmaceutical Co., Ltd.

Headquarters: Jiangsu, China
Key Offering: Pharmaceutical Grade Lopromide

Jiangsu Nhool Pharmaceutical is an emerging supplier in the pharmaceutical chemical space, producing lopromide for diagnostic applications. The company is focused on establishing itself as a reliable source for high-purity ingredients in the global market.

Innovation and Quality Initiatives:

• Capacity expansion projects to increase market share

• Investment in analytical and quality assurance infrastructure

Get Full Report Here: Pharmaceutical Grade Lopromide Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Pharmaceutical Grade Lopromide Is Safer and More Accessible

The Pharmaceutical Grade Lopromide market is undergoing a significant transformation. While the core demand from diagnostic imaging remains robust, the industry is focusing on enhancing purity standards, ensuring supply chain security, and expanding access in emerging economies.

📈 Key Trends Shaping the Market:

• Increasing adoption of high-purity (≥99%) lopromide to meet stringent pharmacopeial standards

• Geographic expansion of manufacturing capabilities, particularly in the Asia-Pacific region

• Growing emphasis on supply chain diversification and resilience post-pandemic

• R&D into next-generation contrast agents with improved safety profiles

Get Full Report Here: Pharmaceutical Grade Lopromide Market – View in Detailed Research Report

The companies listed above are not only supplying a critical diagnostic ingredient—they’re enabling the advancement of global healthcare through reliable and high-quality medical imaging.